Sharps technology, inc. announces stockholders' approval of reverse stock split ratio and effective date

New york, oct. 14, 2024 (globe newswire) -- sharps technology, inc.  (nasdaq: “stss” and “stssw”) ("sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it will effect a one-for-22 reverse stock split (the "reverse split") of its common stock, par value $0.0001 per share (the "common stock"), that will become effective on october 15, 2024 at 11:59 pm eastern time, before the opening of trading on the nasdaq capital market ("nasdaq"). sharps has requested that its common stock begin trading on october 16, 2024, on a post-reverse split basis on the nasdaq under the existing symbol "stss".
STSS Ratings Summary
STSS Quant Ranking